Anixa Biosciences, Inc.【ANIX】 利益剰余金の推移

(単位:千ドル) 利益剰余金 前年比(%)
2Q25 -246,724 +5.2%
1Q25 -243,934 +5.4%
4Q24 -240,750 +5.5%
3Q24 -237,867 +5.5%
2Q24 -234,590 +5.2%
1Q24 -231,451 +4.9%
4Q23 -228,196 +4.5%
3Q23 -225,506 +4.9%
2Q23 -222,995 +5.1%
1Q23 -220,707 +5.8%
4Q22 -218,385 +6.6%
3Q22 -214,909 +7.0%
2Q22 -212,163 +8.0%
1Q22 -208,619 +7.5%
4Q21 -204,791 +6.8%
3Q21 -200,777 +5.9%
2Q21 -196,443 +5.0%
1Q21 -194,044 +5.2%
4Q20 -191,836 +5.5%
3Q20 -189,612 +5.5%
2Q20 -187,050 +5.3%
1Q20 -184,410 +5.3%
4Q19 -181,818 +6.8%
3Q19 -179,730 +9.0%
2Q19 -177,590 +11.4%
1Q19 -175,053 +10.8%
4Q18 -170,171 +9.0%
3Q18 -164,868 +6.8%
2Q18 -159,391 +4.5%
1Q18 -158,013 +3.4%
4Q17 -156,175 -
3Q17 -154,389 +2.8%
2Q17 -152,594 +2.4%
1Q17 -152,755 +3.4%
3Q16 -150,118 +3.6%
2Q16 -149,014 +4.0%
1Q16 -147,742 +4.8%
4Q15 -146,149 +1.0%
3Q15 -144,857 +2.3%
2Q15 -143,255 +0.9%
1Q15 -141,018 +1.6%
4Q14 -144,770 -
3Q14 -141,617 -
2Q14 -142,028 -
1Q14 -138,778 -
4Q12 -125,084 +3.5%
3Q12 -123,223 -
2Q12 -122,594 -
1Q12 -121,717 -
4Q11 -120,831 -